Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000935836-25-000388·EcoR1 Capital, LLC
Schedule 13D ownership disclosure
ITEOS THERAPEUTICS INC
Common Stock · CUSIP: 46565G104
Event date: 2025-05-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EcoR1 Capital, LLCReported CIK 0001587114
Shares: 10,688,978.00 · Class: 27.9%
- Oleg NodelmanReported CIK 0001454385
Shares: 10,688,978.00 · Class: 27.9%
- EcoR1 Capital Fund Qualified, L.P.Reported CIK 0001598292
Shares: 10,020,210.00 · Class: 26.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000388
- Form type
- SCHEDULE 13D
- Filer
- EcoR1 Capital, LLC
- CIK
- CIK 1587114
- Filed
- May 16, 2025
- Reporting period
- May 15, 2025
- Description
- Schedule 13D beneficial ownership